Compartilhar
Informação da revista
Número
Vol. 47. Núm. S2.
XVI Eurasian Hematology Oncology Congress
(Julho 2025)
PREDİCTİON OF THE RİSK OF LEUKEMİA DEVELOPMENT İN AGED HEALTHY POPULATİON: IMPLEMENTATİON İN THE PUBLİC HEALTH SYSTEM
Francesco Frassoni, Roberto Tedone, Emanuela Marcenaro, Giorgio Piastra, Davide Guerr
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103875
Acesso de texto completo
VENETOCLAX-BASED VERSUS 7+3 INDUCTION THERAPY IN FIT YOUNGER ADULTS WITH NEWLY DIAGNOSED NON-CBF AML
Dmitrii Zhogolev, Nikita Pastukhov, Bella Aybova, Anna Smirnova, Ivan Moiseev, Sergey Bondarenko, Alexander Kulagin
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103876
Acesso de texto completo
PREDICTORS OF RESPONSE TO RUXOLITINIB THERAPY IN PATIENTS WITH MYELOFIBROSIS
Irina Turtanova, Maria Barabanshchikova, Elena Morozova, Tatiana Gindina, Tatiana Shneyder, Natalia Dorofeeva, Roman Vaschenkov, Nadezhda Medvedeva, Alexander Kulagin
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103877
Acesso de texto completo
A FUSION OF NUP214 TO ABL1 ON AMPLIFIED EPISOMES IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CASE REPORT AND LITERATURE REVIEW
Jiantuo Liu, Hongrui Li, Li Jiang, Xiangjun Chen, Yanli He
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103879
Acesso de texto completo
CYTOGENETIC FEATURES OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH INTRACHROMOSOMAL AMPLIFICATION OF CHROMOSOME 21
Jiantuo Liu, Hongrui Li, Li Jiang, Ping Zhang, Shanlin Zheng, Xuekui Qiu, Haiqin Zhang
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103881
Acesso de texto completo
IMMUNOPHENOTYPIC CHARACTERISTICS AND TREATMENT OUTCOME OF T-ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS; AN IRAQI CENTER EXPERIENCE
Abdulsalam Al-Ani, Alaadin Sahham Naji, Luma Essa Hamodi, Alaa Fadhil Alwan
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103882
Acesso de texto completo
DYNAMIC BALANCE EVALUATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA UNDERGOING CONSOLIDATION THERAPY
Fulya Ipek-Erdem, Sena Sonkaya, Arzu Genç, Şebnem Yılmaz
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103883
Acesso de texto completo
OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER EXPERIENCE
Yakup Unsal, Muhammed Murati, Guler Delibalta, Serdar Bedii Omay
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103887
Acesso de texto completo
ANALYSIS OF RESPONSE TO FIRST-LINE THERAPY WITH IMATINIB IN AZERBAIJANI CML PATIENTS
Aypara Hasanova, Chingiz Asadov, Aytan Shirinova, Gunay Aliyeva, Zohra Alimirzoyeva
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103892
Acesso de texto completo
OUTCOMES OF DIFFUSE LARGE B-CELL LYMPHOMA IN OLDER ADULTS TREATED IN RESOURCE-CONSTRAINED SETTINGS
Natasha Ali, Raheel Iftikhar, Zeeshan Khan, Usman Ahmed, Humera Mahmood, Zeba Aziz
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103893
Acesso de texto completo
METHOTREXATE-ASSOCIATED STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS: TWO CASE REPORTS
Yakup Unsal, Muhammed Murati, Guler Delibalta, Serdar Bedii Omay, Vildan Yazici, Nedim Polat
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103894
Acesso de texto completo
RITUXIMAB WITH INVOLVED FIELD IRRADIATION FOR EARLY-STAGE DIFFUSE LARGE CELL LYMPHOMA
Vera Kovalskaya, Natalya Falaleeva, Stanislav Shklyaev, Andrey Chelmakov, Ludmila Grivtsova, Marwa Abdelgawad, Ahmed Mubarek
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103895
Acesso de texto completo
CASES OF PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA TREATED WITH SYSTEMIC OR LOCAL THERAPY
Müzeyyen Aslı Ergözoplu, Berksoy Şahin, Ertuğrul Bayram, Esra Gökçe
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103896
Acesso de texto completo
CHIC2 DELETION-ASSOCIATED HYPEREOSINOPHILIA AND SUBSEQUENT JAK2 V617F POSITIVE THROMBOCYTOSIS
Mürüvvet Seda AYDIN, Emel Isleyen, Funda Ceran, Simten Dagdas, Gulsum Ozet
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103899
Acesso de texto completo
LYSOZYME-INDUCED NEPHROPATHY IN CMML: A RARE BUT SIGNIFICANT COMPLICATION REQUIRING EARLY RECOGNITION AND INTERVENTION
Alfadil Haroon, Mohamed Kindawi, Ahmed S Alotaibi, Ali Debsan Alahmari, Hazzaa Alzahrani, Mansour Alfayez, syed Osman Ahmed
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103900
Acesso de texto completo
ASSESSMENT OF INTERPHASE FLUORESCENCE IN SITU HYBRIDIZATION (FISH) TEST IN A PATIENT WITH MULTIPLE MYELOMA: EXPERIENCE OF OUR MEDICAL GENETICS DEPARTMENT
Fatma Turki, Imen Rezgui, Faten Kallel, Moez Mdhaffer, Hassen Kamoun, Rim Frikha
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103904
Acesso de texto completo
THE SUCCESS LIES ON CLINICAL SUSPECT: THE SYNCHRONOUS CANCERS PRESENTING AS PULMONARY AND VERTEBRAL MASS LESIONS
Ulviyya Hasanzade, Metban Mastanzade, Sevgi Kalayoğlu Beşışık
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103906
Acesso de texto completo
ACUTE LYMPHOBLASTIC LEUKEMIA DIAGNOSED FOUR YEARS AFTER HSCT IN A BETA THALASSEMIA PATIENT: A CLINICAL CASE
Samira Hasanova, Huseyn Kerimov, Avesta Allahverdiyeva, Azer Kerimov, Nargiz Aliyeva, Seher İsmayilova
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103907
Acesso de texto completo
INVESTIGATION OF THE RELATIONSHIP BETWEEN COMPASSION AND BURNOUT AMONG HEMATOLOGIST AND ONCOLOGIST
Nisa Aliş, Aze Buyruk, Birol Güvenç, Berksoy Şahin, Naciye Nur Tozluklu
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103908
Acesso de texto completo
COLD AGGLUTININ DISEASE IN A PATIENT WITH WALDENSTRÖM’S MACROGLOBULINEMIA: A DIAGNOSTIC AND THERAPEUTIC CHALLENGE
Ceren Kısa, Feride Aslanca, Melisa Ural, Birol Güvenç
Hematol Transfus Cell Ther. 2025;47 Supl 2: 103911
Acesso de texto completo
Carregando mais artigos...
Publicar em
Hematology, Transfusion and Cell Therapy
